No article text was recorded for this version.
unmet needs in cardiovascular disease treatment
Version 1 of 151 papers69 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Identification of Metabolism-Related Hub Genes in Heart Failure via Comprehensive Transcriptome Analysis
- Blog: Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure
- Blog: Manganese therapy for dyslipidemia and plaque reversal in murine models
- Blog: HIF-1α in heart: Protective mechanisms
- Blog: Identification of ferroptosis-related genes in heart tissues of patients with hypertrophic cardiomyopathy
- Blog: The Cardioprotective Effects of 4-O-(2″-O-acetyl-6″-O- P-coumaroyl-β-D-glucopyranosyl)-P-coumaric Acid (4-ACGC) on Chronic Heart Failure.
- Blog: Lysosomal-Associated Protein Transmembrane 5 Functions as a Novel Negative Regulator of Pathological Cardiac Hypertrophy
- Blog: Medioresinol from Eucommiae cortex improves myocardial infarction-induced heart failure through activation of the PI3K/AKT/mTOR pathway: A network analysis and experimental study
- Blog: Clinical efficacy and hemodynamic effects of levosimendan in cardiac surgery patients after surgery
- Blog: GSTM2 alleviates heart failure by inhibiting DNA damage in cardiomyocytes
- Blog: Differential mRNA Expression and Circular RNA-Based Competitive Endogenous RNA Networks in the Three Stages of Heart Failure in Transverse Aortic Constriction Mice
- Blog: Identification of Novel Single-Nucleotide Variants With Potential of Mediating Malfunction of MicroRNA in Congenital Heart Disease
- Blog: Endothelial cell delivery for cardiovascular therapy
- Blog: Circular RNAs in Cardiovascular Diseases: Molecular Mechanisms, Therapeutic Advances, and Innovations
- Blog: The Key Role and Mechanism of Oxidative Stress in Hypertrophic Cardiomyopathy: A Systematic Exploration Based on Multi-Omics Analysis and Experimental Validation
- Blog: Pharmacological Mechanisms of Tinglizi against Chronic Heart Failure Determined by Network Pharmacology and Molecular Docking
- Blog: Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies
- Blog: Full-Length Transcriptome Sequencing: An Insight Into the Dog Model of Heart Failure
- Blog: CYP2C19 metabolizer phenotypes may affect the efficacy of statins on lowering small dense low-density lipoprotein cholesterol of patients with coronary artery disease
- Blog: Balancing the benefits and risks of colchicine use among patients with atherosclerotic cardiovascular disease: an umbrella review of meta-analyses of randomised controlled trials
- Blog: A single-center observational study on the efficacy of percutaneous coronary intervention for ischemic heart failure
- Blog: Functional analysis of <i>HECA</i> variants identified in congenital heart disease in the Chinese population
- Blog: Synergistic effects of notoginsenoside R1 and saikosaponin B2 in atherosclerosis: A novel approach targeting PI3K/AKT/mTOR pathway and macrophage autophagy
- Blog: Successful Use of Pulmonary Vasodilators in Acute Chest Syndrome Complicated by Persistent Right Ventricular Failure
- Blog: Empirical Mode Decomposition as a Novel Approach to Study Heart Rate Variability in Congestive Heart Failure Assessment
- Blog: A circRNA–miRNA–mRNA network analysis underlying pathogenesis of human heart failure
- Blog: Mutations in Hnrnpa1 cause congenital heart defects
- Blog: Cardiomyocyte‐Enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3 Deubiquitination
- Blog: Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis
- Blog: Personalized Computer Simulation of Diastolic Function in Heart Failure
- Blog: Analysis of Function Role and Long Noncoding RNA Expression in Chronic Heart Failure Rats Treated with Hui Yang Jiu Ji Decoction
- Blog: Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of Guanxin Shutong capsule in treating heart failure
- Blog: Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease
- Blog: Salvia miltiorrhiza Extract Prevents the Occurrence of Early Atherosclerosisin Apoe -/- Mice via TLR4/ NF-kB Pathway
- Blog: A PKB-SPEG signaling nexus links insulin resistance with diabetic cardiomyopathy by regulating calcium homeostasis
- Blog: Phosphatidylinositol 4-Kinase IIIβ: A Therapeutic Target for Contractile Dysfunction in Hypertrophic Cardiomyocytes
- Blog: Shexiang Tongxin Dropping Pill Protects Against Chronic Heart Failure in Mice via Inhibiting the ERK/MAPK and TGF-β Signaling Pathways
- Blog: Deletion of Ptpmt1 by αMHC-Cre in Mice Results in Left Ventricular Non-Compaction
- Blog: MARK4 controls ischaemic heart failure through microtubule detyrosination
- Blog: ACE-inhibition induces a cardioprotective transcriptional response in the metabolic syndrome heart
- Blog: ANGPTL3 accelerates atherosclerotic progression via direct regulation of M1 macrophage activation in plaque
- Blog: A study of changes in deformation and metabolism in the left ventricle as a function of hypertrophy in spontaneous hypertensive rats using microPET technology
- Blog: CNPase, a 2′,3′-Cyclic-nucleotide 3′-phosphodiesterase, as a Therapeutic Target to Attenuate Cardiac Hypertrophy by Enhancing Mitochondrial Energy Production
- Blog: Omics research in the field of heart failure: A bibliometric analysis from 2008 to 2024
- Blog: Cardiomyocyte lncRNA Cpat maintains cardiac homeostasis and mitochondria function by targeting citrate synthase acetylation
- Blog: Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach
- Blog: Biejiajian Pill Ameliorates Diabetes-Associated Atherosclerosis through Inhibition of the NLRP3 Inflammasome
- Blog: Decoding the Kruppel-like Transcription Factors in Atherosclerosis: Insight from Molecular and Translational Perspectives
- Blog: Genetic and environmental determinants of diastolic heart function
- Blog: Overexpression of macrophage migration inhibitory factor protects against pressure overload‐induced cardiac hypertrophy through regulating the miR‐29b‐3p/HBP1 axis
- Blog: Analysis of changes in circular RNA expression and construction of ceRNA networks in human dilated cardiomyopathy
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_unmet_needs_in_cardiovascular_disease_tr_7aad4d19,
title = {unmet needs in cardiovascular disease treatment},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/unmet-needs-in-cardiovascular-disease-treatment/rdr_7aad4d19b70c4670916a45bad6d67ca5},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_unmet_needs_in_cardiovascular_disease_tr_7aad4d19_v1,
title = {unmet needs in cardiovascular disease treatment},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/unmet-needs-in-cardiovascular-disease-treatment/rdr_7aad4d19b70c4670916a45bad6d67ca5/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}